Course curriculum

  • 1

    Hematology/Immunology

    • 13-valent pneumococcal (PCV13) vaccine in children (January 2020)

    • Atopic dermatitis - 3Qs (March 2020)

    • Atopic dermatitis in children - 2Qs (March 2020)

    • Autoimmune hemolytic anemia (September 2018)

    • Cervical adenopathy - 2Qs (March 2020)

    • Crohn's disease - 3Qs (March 2019)

    • Drug-induced angioedema - 2Qs (January 2019)

    • Eosinophilia - 2Qs (May 2020)

    • Erythema multiforme (November 2019)

    • Graves disease (September 2018)

    • IgA nephropathy - 2Qs (September 2019)

    • Immunizations and adults with HIV - 2Qs (September 2019)

    • Immunizations and children with HIV (September 2019)

    • Kawasaki disease (May 2019)

    • Leukotriene receptor antagonists - 2Qs (November 2018)

    • Measles - 2Qs (November 2018)

    • Meningococcal ACWY vaccines - 2Qs (November 2018)

    • Meningococcal type B vaccine (November 2018)

    • Peanut allergy (March 2019)

    • Penicillin allergy (September 2019)

    • Psoriasis comorbidities - 2Qs (March 2019)

    • Psoriatic arthritis (November 2019)

    • Reactions to contrast - 3Qs (July 2019)

    • Rheumatoid arthritis-associated lung disease (July 2019)

    • Serogroup B meningococcal vaccine (July 2019)

    • Systemic juvenile idiopathic arthritis - 2Qs (May 2019)

    • Transfusion reactions - 3Qs (March 2019)

    • Travel and polio - 2Qs (January 2020)

    • Travel vaccinations during pregnancy and lactation (January 2020)

    • Yellow fever - 2Qs (September 2019)